Record High Revenue from Specialty Portfolio
Revenue from UMC's specialty portfolio hit a record high in Q3 2024, accounting for 53.1% of total sales.
Wafer Shipment Increase
Wafer shipments grew 7.8% sequentially due to strong demand for 22- and 28-nanometer products.
Stable ASP and Technology Development
ASP remained flat, demonstrating pricing resilience amidst market conditions. UMC continues to invest significantly in technology development.
Successful 22/28-nanometer Growth
UMC's 22/28-nanometer revenue reached a record high of 35% of total revenue in Q3 2024.
International Diversification
UMC's diversified manufacturing footprint continues to support customer strategies, with new fab expansion in Singapore nearing completion.